Helicobacter pylori Infection Accelerates Gene Expression of Glicentin in the Gastric Mucosa: Its Association with Intestinal Metaplasia of the Stomach

References

• Warren J R, Marshall B J. Unidentified curved bascillus on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273–5
   PubMed Web of Science ®Google Scholar
• Stemraermann G N. Intestinal metaplasia of the stomach. Cancer 1994; 74: 556–64
   PubMed Web of Science ®Google Scholar
• Kuipers E J, Uyterlinede A M, Pena A S, Roosendaal R, Pars G, Nelis G, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525–8
   PubMed Web of Science ®Google Scholar
• Craanen M E, Dekker W, Blok P, Fcrwerda J, Tytgat G NJ. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 1992; 33: 16–20
   PubMed Web of Science ®Google Scholar
• Correa P. The new era of cancer epidemiology. Cancer Epidemiol Biomarkers Prevention 1991; 1: 5–11
   PubMed Web of Science ®Google Scholar
• Morson B G. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 1995; 9: 377–85
   Google Scholar
• Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearance. Gan 1968; 59: 251–8
   PubMedGoogle Scholar
• Yokozaki H, Tahara E. Genetic alterations in precancerous lesions of the stomach. Cancer Res Clin (In Japanese with English Abstract) 1993; 2: 148–54
   Google Scholar
• Soman N R, Correa P, Ruiz B A, Wogan G N. The TPR.-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc Natl Acad Sci USA 1991; 88: 4892–6
   PubMed Web of Science ®Google Scholar
• Tahara E, Kuniyasu H, Yasui W, Yokozaki H. Gene alterations in intestinal metaplasia and gastric cancer. Eur J Gastroenterol Hepatol 1994; 6(Suppl 1)597–602
   Google Scholar
• Personnet J, Friedman G D, Vandersteen D P, Chang Y, Vogelman J H, Orentreich N, et al. Helicobacter pylori infection and risk of gastric carcinoma. N Engl J Med 1991; 325: 1127–31
   PubMed Web of Science ®Google Scholar
• Nomura A, Stemmermann G N, Chyou P H, Kato I, Perez-Perez Gl, Blaser M J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132–6
   PubMed Web of Science ®Google Scholar
• The Eurogasl Study Group. An international association between Helicobacter pvlori infection and gastric cancer. Lancet 1993; 341: 1359–62
   PubMed Web of Science ®Google Scholar
• Thim L, Moody A J. The primary structure of porcine glicentin (preproglucagon). Reg Pept 1981; 2: 139–50
   PubMedGoogle Scholar
• Solcia E, Capella C, Buffa R, Usellini L, Frigerio B, Fontana P. Endocrine cells of the gastrointestinal tract and related tumors. Pathobiol Ann 1979; 9: 163–204
   PubMedGoogle Scholar
• Bloom S R, Polak J M. Gut hormone overview. Gut hormones, S R Bloom. Churchill Livingstone, London 1978; 3–18
   Google Scholar
• Tsutsunii Y, Nagura H, Watanabe K, Yanaihara N. A novel subtyping of intestinal metaplasia of the stomach, with special reference to the histochemical characterizations of endocrine cells. Virchows Arch (Pathol Anat) 1983; 401: 73–88
   Google Scholar
• Bordi C, Pavazzola M. Endocrine cells in the intestinal metaplasia of gastric mucosa. Am J Pathol 1979; 96: 391–8
   PubMed Web of Science ®Google Scholar
• Nielsen H O, Teglbjaerg P S, Hage E. Gastrin and enteroglucagon in human antrum, with special reference to intestinal metaplasia. Scand .J Gastroenterol 1979; 14: 101–3
   PubMed Web of Science ®Google Scholar
• Tsutsunii Y, Osamura R Y, Nagura H, Watanabe K, Yahaihara N. Immunohistochemical studies on gastrointestinal hormones in the intestinal metaplasia of the stomach. Gut peptide and ulcer, A Miyoshi. Biochemical Research Foundation, Tokyo 1983; 171–9
   Google Scholar
• Moody A J, Thim L, Kirkrgaard H. Glicentin: its structure and possible function as an enteroglucagon. Gut peptides and ulcer, A Miyoshi. Biochemical Research Foundation, Tokyo 1983; 20–6
   Google Scholar
• Ito H, Yokozaki H, Hata J, Mandai K, Tahara E. Glicentin-containing cells in intestinal metaplasia, adenoma and carcinoma of the stomach. Virchows Arch (Pathol Anat) 1984; 404: 17–29
   Google Scholar
• Nanji A A, Zhau S, Sadraden S MH, Waxman D J. Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hematology 1994; 19: 1483–7
   Google Scholar
• Suzuki S, Suzuki H, Endo M, Takemoto T, Kondo T, Nakayama K. Endoscopic dyeing method for diagnosis of early cancer and intestinal metaplasia of the stomach. Endoscopy 1973; 5: 124–8
   Web of Science ®Google Scholar
• Fukuda R, Satoh S, Nguyen T X, Uchida Y, Kohge N, Akagi S, et al. Expression of cytokine raRNA in the liver of chronic-hepatitis C: comparison with chronic hepatitis B. J Gastroenterol 1995; 31: 41–7
   Google Scholar
• Rothenberg M E, Eilertson C D, Klein K, Zhou Y, Lindverg I, McDonald J M, et al. Processing of mouse proglucagon by recombinant prohormone convertase 1 and immunopurified prohormone convertase 2 in vitro. J Biol Chem 1995; 270: 10136–46
   PubMed Web of Science ®Google Scholar
• Spicer S S. Diamine methods for differentiating mucosubstances histochemically. J Histochem Cytochem 1965; 13: 211–34
   PubMed Web of Science ®Google Scholar
• Satoh K, Kimura K, Yoshida Y, Taniguchi Y, Kasano T, Kihira K, et al. Helicobacter pylori infection and the extension of atrophic gastritis. Eur J Gastroenterol Hepatol 1993; 5(Suppl 1)115–7
   Google Scholar
• Cover T L, Blaser M J. Purification and characterization of the vacuolating toxin from Helicobacter pvlori. J Biol Chem 1992; 267: 10570–5
   PubMed Web of Science ®Google Scholar
• Lopez L C, Frazier M L, Su C J, Kumura A, Saunders G F. Mammalian pancreatic preproglucagon contains three glucagon-related peptides. Proc Natl Acad Sci USA 1983; 80: 5485–9
   PubMed Web of Science ®Google Scholar
• Moody A AJ, Hoist J J, Thim L, Jensen S L. Relationship of glicentin to proglucagon and glucagon in the porcine pancreas. Nature 1981; 289: 514–6
   PubMed Web of Science ®Google Scholar
• Bloom S R, Polak J M. Enteroglucagon and the gut hormone profile of intestinal adaptation. Mechanism of intestinal adaptation, J WL Robinson, R H Dowling, E O Riecken. MTP Press, Lancaster, Boston, The Hague 1981; 189–99
   Google Scholar
• Jacobs L R, Polaak J M, Bloom S R, Dowling R H. Intestinal mucosal and fasting plasma levels of immunoreactive enteroglucagon in three models of intestinal adaptation: resection, hypothermic hyperphagia and lactation in the rat. Mechanism of intestinal adaptation, J WL Robinson, R H Dowling, E O Riecken. MTP Press, Lancaster, Boston, The Hague 1981; 231–42
   Google Scholar
• Kimura K, Satoh K, Yoshida Y, Taniguchi Y, Ldo K, Takemoto T. Chronological extension of atrophic gastritis and intestinal metaplasia in normal Japanese. Eur J Gastroenterol Hepatol 1993; 5(Suppl 1)85–91
   Google Scholar
• Correa P, Haenzel W, Cuello C, et al. Gastric precancerous process in a high-risk population: cohort follow-up. Cancer Res 1990; 50: 4737
   PubMed Web of Science ®Google Scholar
• Tsutsumi Y, Nagura H, Watanabe K. Immune aspects of intestinal metaplasia of the stomach–an immunohistochemical study. Virchows Arch (Pathol Anat) 1984; 403: 345–59
   Google Scholar
• Tsutsumi Y. Pathophysiological significance of intestinal metaplasia of the gastric mucosa–an immunohistochemical approach. Gastrointestinal function. Regulation and distribution8th ed., Y Kasuya, M Tsuchiya, F Nagao, Y Matsuo. Excerpta Medica, Tokyo 1986; 4: 15–37
   Google Scholar
• Correa P. Human gastric carcinogenesis: A multistep and multifactorial process—First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6635–40
   Web of Science ®Google Scholar
• Correa P, Shiaao Y. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994; 54: 1941s–3s
   Web of Science ®Google Scholar